Compare PIPR & NOVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PIPR | NOVT |
|---|---|---|
| Founded | 1895 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Industrial Machinery/Components |
| Sector | Finance | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 4.7B |
| IPO Year | 2003 | 1999 |
| Metric | PIPR | NOVT |
|---|---|---|
| Price | $76.70 | $164.87 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 1 |
| Target Price | $91.38 | ★ $144.00 |
| AVG Volume (30 Days) | ★ 485.4K | 461.7K |
| Earning Date | 05-01-2026 | 05-11-2026 |
| Dividend Yield | ★ 2.26% | N/A |
| EPS Growth | ★ 54.49 | N/A |
| EPS | ★ 0.92 | 0.51 |
| Revenue | ★ $1,904,217,000.00 | $521,290,000.00 |
| Revenue This Year | $12.30 | $8.61 |
| Revenue Next Year | $13.55 | $6.57 |
| P/E Ratio | ★ $82.21 | $327.33 |
| Revenue Growth | 24.33 | ★ 35.49 |
| 52 Week Low | $72.48 | $98.27 |
| 52 Week High | $380.26 | $171.85 |
| Indicator | PIPR | NOVT |
|---|---|---|
| Relative Strength Index (RSI) | 27.31 | 67.20 |
| Support Level | $76.20 | $111.05 |
| Resistance Level | $82.17 | N/A |
| Average True Range (ATR) | 2.09 | 6.40 |
| MACD | 1.66 | 0.40 |
| Stochastic Oscillator | 22.97 | 78.32 |
Piper Sandler Cos is an investment bank and institutional securities firm, serving the needs of corporations, private equity groups, public entities, non-profit entities and institutional investors in the United States (U.S.) and internationally. The company provides a broad set of products and services, including financial advisory services; equity and debt capital markets products; public finance services; institutional brokerage services; fundamental equity and macro research services; fixed income services; and alternative asset management strategies. It generates maximum revenue from Advisory services followed by Equity financing.
Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.